HBM Pharma s.r.o.
ActiveKey figures
Key figures
2025Summary: HBM Pharma s.r.o.
What kind of company is it?
HBM Pharma s.r.o. (IČO 31560784) is a limited liability company (s.r.o.). The company was incorporated in 1992 and has existed for 34 years. Registered office according to the register: Martin. Main activity according to the Statistical Office: výroba farmaceutických prípravkov (SK NACE 2120). Size category by number of employees: 250–499 employees.
Who runs the company and who owns it?
The statutory body has 2 members. According to the register, the company has one shareholder. The supervisory board has 3 members. The registered capital is 13 829 915 €.
How is the company doing financially?
Revenue for 2025 was 42 017 944 €, down 2,4 % on the previous year (43 051 512 €). From 2020 to 2025, revenue grew by an average of 2,7 % per year. Net profit for 2025 was 2 366 911 € (5,6 % of revenue). The company was profitable in all 6 reported years. Personnel costs for 2025 were 19 748 640 €. At the end of 2025 the company had total assets of 44 487 878 € and equity of 34 952 160 € (equity ratio 78,6 %).
Where does the data come from and how current is it?
Company and people data come from the Register of Legal Entities (Statistical Office SR, CC BY 4.0) and financial statements from the Register of Financial Statements (Ministry of Finance SR); icoprofil.sk updates them daily. Data as of 16. 11. 2026. Changes, averages and ratios are calculated by icoprofil.sk from open data and are not an official assessment.
Summary of annual reports2020–2025
| 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Revenue (net turnover) | 40 141 595 | 37 772 884 | 42 907 487 | 43 051 512 | 42 017 944 |
| Profit for the reporting year | 3 943 443 | 2 311 475 | 4 730 593 | 3 362 274 | 2 366 911 |
| Retained earnings of previous periods | 2 984 476 | 6 927 919 | 9 239 394 | 13 969 986 | 17 332 261 |
| Total assets | 35 515 566 | 35 612 786 | 41 350 350 | 44 165 185 | 44 487 878 |
| Total liabilities | 13 048 106 | 10 857 756 | 11 888 549 | 11 375 855 | 9 361 748 |
| Total equity | 22 180 907 | 24 492 382 | 29 222 975 | 32 585 248 | 34 952 160 |
| Calculated dividends | 0 | 0 | 0 | 0 | 0 |
A dash (—) means the report has not been filed or the line is not reported; 0 is a zero stated in the report.
Documents in the Register of Financial Statements17
- 2025 Správa audítora
- 2025 Úč POD · 12 pp.
- 2025 Úč POD
- 2024 Správa audítora
- 2024 Úč POD · 12 pp.
- 2024 Úč POD
- 2023 Správa audítora
- 2023 Úč POD · 12 pp.
- 2023 Úč POD
- 2022 Oznámenie o dátume schválenia účtovnej závierky · 1 pp.
- 2022 Správa audítora
- 2022 Úč POD · 12 pp.
- 2022 Úč POD
- 2021 Oznámenie o dátume schválenia účtovnej závierky · 1 pp.
- 2021 Správa audítora
- 2021 Úč POD · 12 pp.
- 2021 Úč POD
Documents open directly on registeruz.sk (Ministry of Finance of the Slovak Republic).
Similar companies
- G.V.Pharma, a.s. · Hlohovec
- Pharmagal, spol. s.r.o. · Nitra
- hameln rds s. r. o. · Modra
- BEL - MIDITECH, s.r.o. · Kráľová pri Senci
- MED-PLANT, s.r.o. · Modra
- VALOVIČ, s.r.o. · Bratislava
- GALVEX, spol. s r.o. · Banská Bystrica
- PANACEA, s.r.o. · Žilina
- IMUNA PHARM, a.s. · Šarišské Michaľany
- PHARMAGAL - BIO, spol. s r.o. · Nitra